Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Andrology

Free Subscription Articles published in Prostate Retrieve available abstracts of 57 articles: HTML format

Single Articles

November 2025
1. MENDOZA-CHUCTAYA G, Rodrigo-Ramos K, Aycachi-Centeno L, Taype-Rondan A, et al
   Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review.
   Prostate. 2025 Nov 16. doi: 10.1002/pros.70096.
   PubMed     Abstract available
   
   
   
2. QUARTA L, Bandini M, Corsini C, Cattafi F, et al
   Assessing Predictors of Failure After Bladder Neck Incision in Patients Who Developed Bladder Neck Stenosis Following Transurethral Surgery for Benign Prostatic Enlargement.
   Prostate. 2025;85:1424-1431.
   PubMed     Abstract available
   
   
   October 2025
3. BEVILACQUA G, Carino D, Salciccia S, Gentilucci A, et al
   Efficacy of Hexanic Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study.
   Prostate. 2025 Oct 16. doi: 10.1002/pros.70071.
   PubMed     Abstract available
   
   
   
4. CHEN Z, Ma J, Yu X, Liu X, et al
   Zinc Ameliorates Inflammation and Sperm Parameters in Rats With Experimental Autoimmune Prostatitis.
   Prostate. 2025 Oct 2. doi: 10.1002/pros.70067.
   PubMed     Abstract available
   
   
   
5. SCHMIDT J, Ralla B, Maxeiner A, Krediet J, et al
   Minimally Invasive Holmium Laser Enucleation of the Prostate (MiLEP) Vs. HoLEP: Retrospective Analysis of Perioperative Outcomes in a Propensity Score-Matched Cohort.
   Prostate. 2025;85:1299-1306.
   PubMed     Abstract available
   
   
   September 2025
6. ZHU J, Wang J, Gu M, Xu H, et al
   c-Kit-Mediated PI3K/AKT and Wnt/beta-Catenin Signaling Drives Resistance to 5alpha-Reductase Inhibitors in Benign Prostatic Hyperplasia.
   Prostate. 2025 Sep 29. doi: 10.1002/pros.70046.
   PubMed     Abstract available
   
   
   
7. HUNT TC, Malshy K, Steidle M, Li A, et al
   Impact of Testosterone Recovery on Oncologic Outcomes in High-Risk, Localized Prostate Cancer.
   Prostate. 2025 Sep 9. doi: 10.1002/pros.70043.
   PubMed     Abstract available
   
   
   
8. YOON SG, Noh TI, Shim JS, Park MG, et al
   The Efficacy of Transperineal Drainage for Treating Prostatic Abscess: A Comparative Analysis Against Conservative Management.
   Prostate. 2025;85:1161-1167.
   PubMed     Abstract available
   
   
   August 2025
9. XU K, Khan A, Evancho P, Chu M, et al
   Analysis of the Increased Incidence of Aggressive Prostate Cancer After Prior Testicular Cancer.
   Prostate. 2025 Aug 16. doi: 10.1002/pros.70035.
   PubMed     Abstract available
   
   
   
10. BASHI T, Kamshov S, Kidron A, Barnes S, et al
    Prevalence and Characteristics of Prostatic Utricles: A Retrospective MRI Study in Middle-Aged to Elderly Men.
    Prostate. 2025;85:1000-1004.
    PubMed     Abstract available
    
    
    July 2025
11. ABDALI NT, Mohamed YS, Zaki HF, Ramadan LAA, et al
    Probenecid and Eugenol Mitigate Testosterone Induced Benign Prostatic Hyperplasia by Targeting Uric Acid-Induced Inflammation and Pro-Survival Pathways.
    Prostate. 2025 Jul 31. doi: 10.1002/pros.70026.
    PubMed     Abstract available
    
    
    
12. DAGLI I, Uzel T, Canbolat MZ, Demirci A, et al
    The Mediterranean Diet and Benign Prostatic Hyperplasia: A Pathway to Improved Urinary Health.
    Prostate. 2025 Jul 6. doi: 10.1002/pros.70009.
    PubMed     Abstract available
    
    
    June 2025
13. GRUTMAN AJ, Jing Y, Ng DK, Landis PK, et al
    History of Vasectomy Is not Associated With Prostate Cancer Progression in Men on Active Surveillance.
    Prostate. 2025 Jun 23. doi: 10.1002/pros.70001.
    PubMed     Abstract available
    
    
    
14. WENG Y, Ji B
    Serum Levels of Prostate Specific Antigen, Free PSA, [-2]proPSA, fPSA/tPSA Ratio, Prostate Health Index, and Glycosylation Patterns of Free PSA in Patients With Benign Prostatic Hyperplasia Pharmacotherapy: Limitations and Future Directions.
    Prostate. 2025 Jun 22. doi: 10.1002/pros.70003.
    PubMed    
    
    
    
15. LI Y, Wu Z, Ma J, Liu X, et al
    Zinc Attenuates Prostate Hyperplasia and Inflammatory Injury in Obese Rats by Regulating Zinc Homeostasis and Inhibiting the JAK1/STAT3 Pathway.
    Prostate. 2025;85:767-776.
    PubMed     Abstract available
    
    
    
16. SUN A, Rodriguez-Alvarez JS, Harper S, Khooblall P, et al
    The Prostate Microbiome Is Associated With Prostate Size and PSA Level, Independent of Age, in BPH Patients.
    Prostate. 2025;85:850-859.
    PubMed     Abstract available
    
    
    April 2025
17. PAE S, Sakamoto S, Zhao X, Tamura T, et al
    LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After Radiotherapy.
    Prostate. 2025 Apr 2. doi: 10.1002/pros.24899.
    PubMed     Abstract available
    
    
    March 2025
18. GUERRA LHA, da Costa Castro NF, Jubilato FC, Marques LA, et al
    Coconut Oil Mitigates the Effects of Aging on the Mongolian Gerbil Prostate.
    Prostate. 2025;85:395-406.
    PubMed     Abstract available
    
    
    February 2025
19. RINGLER R, Gangwish D, Horning P, Kuperus J, et al
    Does size matter? A single institution's comparison of Aquablation in prostates greater than or less than 150 mL.
    Prostate. 2025;85:140-147.
    PubMed     Abstract available
    
    
    
20. ABDELAZIZ AY, Kishk MA, Meshref A, Elfayomy H, et al
    Safety and Efficacy of Intra-Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study.
    Prostate. 2025;85:243-251.
    PubMed     Abstract available
    
    
    December 2024
21. KONG X, Dong Z, Hu W, Mi J, et al
    The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low-intensity extracorporeal shock wave.
    Prostate. 2024;84:1525-1536.
    PubMed     Abstract available
    
    
    
22. ALVES BB, Gabrich P, Favorito LA
    Prospective results of the minimally invasive laser enucleation of the prostate (MiLEP).
    Prostate. 2024;84:1501-1505.
    PubMed     Abstract available
    
    
    November 2024
23. WARREN CJ, Payne NG, Edmonds VS, Voleti SS, et al
    Quality of Chatbot Information Related to Benign Prostatic Hyperplasia.
    Prostate. 2024 Nov 8. doi: 10.1002/pros.24814.
    PubMed     Abstract available
    
    
    September 2024
24. JIRASKO M, Vitak R, Pecen L, Pinkeova A, et al
    Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy.
    Prostate. 2024 Sep 27. doi: 10.1002/pros.24801.
    PubMed     Abstract available
    
    
    
25. ZHANG P, Wang H, Li P, Fu X, et al
    Assessing state-of-the-art online large language models for patient education regarding prostatitis.
    Prostate. 2024;84:1173-1175.
    PubMed    
    
    
    August 2024
26. IGARASHI T, Mizoguchi S, Matsuoka K, Kamijo T, et al
    Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation.
    Prostate. 2024;84:1016-1024.
    PubMed     Abstract available
    
    
    July 2024
27. LIU TT, Igarashi T, El-Khoury N, Ihejirika N, et al
    Benign prostatic hyperplasia nodules in patients treated with celecoxib and/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport
    Prostate. 2024 Jul 14. doi: 10.1002/pros.24766.
    PubMed     Abstract available
    
    
    May 2024
28. ZHANG Y, Zhou J
    Responses to queries concerning "Performance of large language models on benign prostatic hyperplasia frequently asked questions".
    Prostate. 2024 May 16. doi: 10.1002/pros.24748.
    PubMed    
    
    
    
29. DAUNGSUPAWONG H, Wiwanitkit V
    Large language models and benign prostatic hyperplasia frequently asked questions.
    Prostate. 2024 May 16. doi: 10.1002/pros.24719.
    PubMed    
    
    
    
30. HUA X, Zhang J, Chen J, Feng R, et al
    Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway.
    Prostate. 2024;84:666-681.
    PubMed     Abstract available
    
    
    April 2024
31. ABID A, Piperdi H, Babar M, Loloi J, et al
    Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review.
    Prostate. 2024 Apr 24. doi: 10.1002/pros.24717.
    PubMed     Abstract available
    
    
    
32. ROPER C, Slade A, Caras R, Shelton T, et al
    Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate.
    Prostate. 2024 Apr 1. doi: 10.1002/pros.24697.
    PubMed     Abstract available
    
    
    
33. ZHANG Y, Dong Y, Mei Z, Hou Y, et al
    Performance of large language models on benign prostatic hyperplasia frequently asked questions.
    Prostate. 2024 Apr 1. doi: 10.1002/pros.24699.
    PubMed     Abstract available
    
    
    March 2024
34. ZHAO X, Feng R, Chen J, Jiang Q, et al
    4-Octyl itaconate alleviates experimental autoimmune prostatitis by inhibiting the NLRP3 inflammasome-induced pyroptosis through activating Nrf2/HO-1 pathway.
    Prostate. 2024;84:329-341.
    PubMed     Abstract available
    
    
    February 2024
35. KAMADA S, Sakamoto S, Kinoshita R, Zhao X, et al
    Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
    Prostate. 2024 Feb 27. doi: 10.1002/pros.24679.
    PubMed     Abstract available
    
    
    
36. SHIBAMORI K, Kyoda Y, Shindo T, Hashimoto K, et al
    Maternal diet during gestation affect prostatic tissue component in SHR/Izm offspring.
    Prostate. 2024;84:303-314.
    PubMed     Abstract available
    
    
    January 2024
37. CAVANAUGH D, Urbanucci A, Mohamed NE, Tewari AK, et al
    Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS).
    Prostate. 2024 Jan 9. doi: 10.1002/pros.24656.
    PubMed     Abstract available
    
    
    
38. WHITE JA, Kaninjing ET, Adeniji KA, Jibrin P, et al
    Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.
    Prostate. 2024 Jan 8. doi: 10.1002/pros.24662.
    PubMed     Abstract available
    
    
    
39. JIN R, Forbes CM, Miller NL, Lafin J, et al
    Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
    Prostate. 2024 Jan 3. doi: 10.1002/pros.24661.
    PubMed     Abstract available
    
    
    December 2023
40. LEE KS, Yoo JW, Kim DH, Jeon S, et al
    A prospective, randomized, open-label, parallel trial comparing the efficacy of alpha-blocker or 5alpha-reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyp
    Prostate. 2023 Dec 27. doi: 10.1002/pros.24663.
    PubMed     Abstract available
    
    
    
41. SCHNEIDER AJ, Serrell EC, Grimes M, Wang S, et al
    Histologic inflammation and collagen content are not positively correlated in human BPH.
    Prostate. 2023;83:1529-1536.
    PubMed     Abstract available
    
    
    November 2023
42. MARIOTTI ACH, Heidrich V, Inoue LT, Coser EM, et al
    Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasia.
    Prostate. 2023 Nov 13. doi: 10.1002/pros.24649.
    PubMed     Abstract available
    
    
    October 2023
43. DI H, Wen Y
    Vasectomy and risk of prostate cancer: A Mendelian randomization study and confounder analysis.
    Prostate. 2023 Oct 31. doi: 10.1002/pros.24646.
    PubMed     Abstract available
    
    
    
44. ZHOU H, Xu M, Pan Y, Wang S, et al
    The association between several serum micronutrients and benign prostatic hyperplasia: Results from NHANES 2003-2006.
    Prostate. 2023 Oct 29. doi: 10.1002/pros.24641.
    PubMed     Abstract available
    
    
    
45. HATA J, Matsuoka K, Akaihata H, Meguro S, et al
    The activated complement pathway in the fibrous process of benign prostatic hyperplasia.
    Prostate. 2023 Oct 25. doi: 10.1002/pros.24639.
    PubMed     Abstract available
    
    
    
46. ZHANG Y, Peng R, Chen Z, Zhang W, et al
    Evidence for a causal effect of major depressive disorder, anxiety on prostatitis risk: A univariate and multivariate Mendelian randomization study.
    Prostate. 2023;83:1387-1392.
    PubMed     Abstract available
    
    
    
47. WESTHOFEN T, Bensel M, Schlenker B, Becker A, et al
    The impact of previous inguinal mesh hernioplasty on oncological and patient-reported outcomes following radical prostatectomy.
    Prostate. 2023;83:1313-1322.
    PubMed     Abstract available
    
    
    September 2023
48. FUJIWARA S, Kosaka T, Nishimoto Y, Kamisawa K, et al
    Prognostic significance of serum testosterone level in patients with castration-resistant prostate cancer treated with cabazitaxel.
    Prostate. 2023 Sep 3. doi: 10.1002/pros.24620.
    PubMed     Abstract available
    
    
    July 2023
49. LV K, Yang G, Wu Y, Xia X, et al
    The causal effect of metabolic syndrome and its components on benign prostatic hyperplasia: A univariable and multivariable Mendelian randomization study.
    Prostate. 2023 Jul 16. doi: 10.1002/pros.24598.
    PubMed     Abstract available
    
    
    June 2023
50. SEVIM M, Alkis O, Kartal IG, Kazan HO, et al
    Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
    Prostate. 2023;83:751-758.
    PubMed     Abstract available
    
    
    
51. LI Z, Lao Y, Bai Y, Li W, et al
    Re: Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
    Prostate. 2023;83:896-897.
    PubMed    
    
    
    
52. LEBANI BR, Barcelos ADS, Gouveia DSES, Girotti ME, et al
    The role of transurethral resection of prostate (TURP) in patients with underactive bladder: 12 months follow-up in different grades of detrusor contractility.
    Prostate. 2023;83:857-862.
    PubMed     Abstract available
    
    
    May 2023
53. LEE S, Yoo KH, Kim TS, Cho HJ, et al
    Characteristics of recurrent acute urinary retention in BPH patients in the United States: Retrospective analysis of US-based insurance claims database.
    Prostate. 2023;83:722-728.
    PubMed     Abstract available
    
    
    
54. BABAR M, Loloi J, Tang K, Singh S, et al
    Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Prostate. 2023;83:713-721.
    PubMed     Abstract available
    
    
    April 2023
55. BENGTSEN MB, Heide-Jorgensen U, Borre M, Norgaard M, et al
    Long-term risk of benign prostatic hyperplasia-related surgery and acute urinary retention in men treated with 5-alpha reductase inhibitor versus alpha-blocker monotherapy in routine clinical care.
    Prostate. 2023 Apr 14. doi: 10.1002/pros.24540.
    PubMed     Abstract available
    
    
    March 2023
56. MIYAZAWA Y, Nakamura T, Takezawa Y, Shimizu N, et al
    A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS.
    Prostate. 2023 Mar 9. doi: 10.1002/pros.24514.
    PubMed     Abstract available
    
    
    February 2023
57. BECK J, Rouleau M, Lemire F, Neveu B, et al
    Mass spectrometry redefines optimal testosterone thresholds in prostate cancer patients undergoing androgen deprivation therapy.
    Prostate. 2023 Feb 27. doi: 10.1002/pros.24501.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Andrology is free of charge.